SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-059338
Filing Date
2021-11-15
Accepted
2021-11-15 16:05:59
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_virpaxpharma.htm   iXBRL 10-Q 646390
2 CERTIFICATION f10q0921ex31-1_virpaxpharma.htm EX-31.1 10748
3 CERTIFICATION f10q0921ex31-2_virpaxpharma.htm EX-31.2 10854
4 CERTIFICATION f10q0921ex32-1_virpaxpharma.htm EX-32.1 5375
  Complete submission text file 0001213900-21-059338.txt   3816319

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vrpx-20210930.xsd EX-101.SCH 47702
6 XBRL CALCULATION FILE vrpx-20210930_cal.xml EX-101.CAL 25068
7 XBRL DEFINITION FILE vrpx-20210930_def.xml EX-101.DEF 199625
8 XBRL LABEL FILE vrpx-20210930_lab.xml EX-101.LAB 412711
9 XBRL PRESENTATION FILE vrpx-20210930_pre.xml EX-101.PRE 212495
10 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_virpaxpharma_htm.xml XML 384039
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40064 | Film No.: 211410362
SIC: 2834 Pharmaceutical Preparations